Form D · Biotechnology
Adient Medical, Inc.
Pearland, TX · CIK 0001679378
Offering snapshot reported Oct 3, 2022 · SEC filing
- Reported sold
- $14.3M Offering amount: $14.3M
- Investors reported
- 40 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 26, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 3, 2022 | Initial | $14,314,212 | No comparison | 40 | SEC filing |
| Feb 1, 2021 | Initial | $710,986 | No comparison | 19 | SEC filing |
| Jul 10, 2017 | Initial | $1,735,375 | No comparison | 20 | SEC filing |
| Jul 13, 2016 | Initial | $1,467,138 | No comparison | 20 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-460474
Source: Form D, filed Oct 3, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mitchell Eggers | Director, Executive |
| Michael Hogan | Director |
| Robert Mitchell | Director |
| Robert Tucci | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12234 Shadow Creek Parkway Bldg 8, Ste 106
Pearland, TX, 77584
Pearland, TX, 77584